| 1 | Vertex Pharmaceuticals IncorporatedVRTX | $131.0B | $516.34 |
| 2 | Regeneron Pharmaceuticals, Inc.REGN | $81.3B | $789.45 |
| 3 | Moderna, Inc.MRNA | $62.7B | $158.07 |
| 4 | Revolution Medicines, Inc.RVMD | $41.9B | $196.94 |
| 5 | Alnylam Pharmaceuticals, Inc.ALNY | $32.9B | $245.51 |
| 6 | Roivant Sciences Ltd.ROIV | $28.9B | $39.98 |
| 7 | Insmed IncorporatedINSM | $26.9B | $123.98 |
| 8 | Incyte CorporationINCY | $25.9B | $127.62 |
| 9 | United Therapeutics CorporationUTHR | $21.1B | $497.27 |
| 10 | Jazz Pharmaceuticals plcJAZZ | $15.3B | $243.84 |
| 11 | Neurocrine Biosciences, Inc.NBIX | $15.3B | $151.83 |
| 12 | Exelixis, Inc.EXEL | $14.7B | $58.49 |
| 13 | Summit Therapeutics Inc.SMMT | $14.1B | $17.72 |
| 14 | BridgeBio Pharma, Inc.BBIO | $13.2B | $67.31 |
| 15 | Halozyme Therapeutics, Inc.HALO | $13.0B | $109.68 |
| 16 | BioMarin Pharmaceutical Inc.BMRN | $12.6B | $65.08 |
| 17 | Madrigal Pharmaceuticals, Inc.MDGL | $12.3B | $534.40 |
| 18 | Bio-Techne CorporationTECH | $11.3B | $72.41 |
| 19 | Axsome Therapeutics, Inc.AXSM | $11.0B | $214.28 |
| 20 | Krystal Biotech, Inc.KRYS | $10.0B | $338.75 |
| 21 | 10x Genomics, Inc.TXG | $9.8B | $76.97 |
| 22 | Kymera Therapeutics, Inc.KYMR | $9.7B | $118.48 |
| 23 | Twist Bioscience CorporationTWST | $9.7B | $155.56 |
| 24 | Arrowhead Pharmaceuticals, Inc.ARWR | $9.5B | $67.74 |
| 25 | Protagonist Therapeutics, Inc.PTGX | $9.2B | $143.70 |
| 26 | ImmunityBio, Inc.IBRX | $8.9B | $8.46 |
| 27 | Caris Life Sciences, Inc.CAI | $8.7B | $30.92 |
| 28 | Vaxcyte, Inc.PCVX | $8.7B | $60.37 |
| 29 | Cytokinetics, IncorporatedCYTK | $8.7B | $69.92 |
| 30 | Praxis Precision Medicines, Inc.PRAX | $8.7B | $310.47 |
| 31 | TG Therapeutics, Inc.TGTX | $8.6B | $56.47 |
| 32 | Apogee Therapeutics, Inc.APGE | $8.4B | $135.07 |
| 33 | Spyre Therapeutics, Inc.SYRE | $8.0B | $92.68 |
| 34 | Immunovant, Inc.IMVT | $7.8B | $37.65 |
| 35 | Ionis Pharmaceuticals, Inc.IONS | $7.8B | $46.75 |
| 36 | Rhythm Pharmaceuticals, Inc.RYTM | $6.8B | $99.02 |
| 37 | CG Oncology Inc.CGON | $6.7B | $75.62 |
| 38 | Mirum Pharmaceuticals, Inc.MIRM | $6.0B | $98.82 |
| 39 | Travere Therapeutics, Inc.TVTX | $6.0B | $64.74 |
| 40 | Oruka Therapeutics, Inc.ORKA | $5.9B | $97.73 |
| 41 | Scholar Rock Holding CorporationSRRK | $5.9B | $49.02 |
| 42 | Ligand Pharmaceuticals IncorporatedLGND | $5.7B | $284.70 |
| 43 | PTC Therapeutics, Inc.PTCT | $5.7B | $68.00 |
| 44 | Cogent Biosciences, Inc.COGT | $5.7B | $33.19 |
| 45 | Dianthus Therapeutics, Inc.DNTH | $5.7B | $101.12 |
| 46 | Xenon Pharmaceuticals Inc.XENE | $5.5B | $57.35 |
| 47 | CRISPR Therapeutics AGCRSP | $5.5B | $57.33 |
| 48 | Erasca, Inc.ERAS | $5.3B | $15.34 |
| 49 | Definium Therapeutics, Inc.DFTX | $5.1B | $38.68 |
| 50 | Edgewise Therapeutics, Inc.EWTX | $5.1B | $46.94 |
| 51 | Parabilis Medicines, Inc.PBLS | $4.8B | $40.88 |
| 52 | ACADIA Pharmaceuticals Inc.ACAD | $4.7B | $27.45 |
| 53 | Adaptive Biotechnologies CorporationADPT | $4.6B | $28.55 |
| 54 | Veradermics, IncorporatedMANE | $4.5B | $108.68 |
| 55 | Iovance Biotherapeutics, Inc.IOVA | $4.5B | $10.02 |
| 56 | Relay Therapeutics, Inc.RLAY | $4.2B | $19.19 |
| 57 | Celcuity Inc.CELC | $4.1B | $84.91 |
| 58 | Tango Therapeutics, Inc.TNGX | $3.8B | $23.49 |
| 59 | Amylyx Pharmaceuticals, Inc.AMLX | $3.8B | $33.94 |
| 60 | IDEAYA Biosciences, Inc.IDYA | $3.7B | $38.61 |
| 61 | Enliven Therapeutics, Inc.ELVN | $3.6B | $50.24 |
| 62 | Viking Therapeutics, Inc.VKTX | $3.4B | $29.36 |
| 63 | Tarsus Pharmaceuticals, Inc.TARS | $3.4B | $79.03 |
| 64 | Dyne Therapeutics, Inc.DYN | $3.4B | $18.06 |
| 65 | Arcutis Biotherapeutics, Inc.ARQT | $3.3B | $26.46 |
| 66 | Arcus Biosciences, Inc.RCUS | $3.2B | $25.54 |
| 67 | Denali Therapeutics Inc.DNLI | $3.2B | $20.13 |
| 68 | MBX Biosciences, Inc. Common StockMBX | $3.0B | $63.89 |
| 69 | Precigen, Inc.PGEN | $2.8B | $7.87 |
| 70 | Disc Medicine, Inc.IRON | $2.7B | $69.18 |
| 71 | Nurix Therapeutics, Inc.NRIX | $2.6B | $25.50 |
| 72 | Celldex Therapeutics, Inc.CLDX | $2.6B | $38.98 |
| 73 | Beam Therapeutics Inc.BEAM | $2.5B | $24.67 |
| 74 | Viridian Therapeutics, Inc.VRDN | $2.5B | $21.93 |
| 75 | Harmony Biosciences Holdings, Inc.HRMY | $2.5B | $42.74 |
| 76 | Mineralys Therapeutics, Inc.MLYS | $2.5B | $27.98 |
| 77 | Vera Therapeutics, Inc.VERA | $2.5B | $34.27 |
| 78 | Immunome, Inc.IMNM | $2.3B | $23.93 |
| 79 | Ocular Therapeutix, Inc.OCUL | $2.2B | $10.14 |
| 80 | Alamar Biosciences, Inc.ALMR | $2.2B | $32.01 |
| 81 | Palvella Therapeutics, Inc.PVLA | $2.2B | $154.32 |
| 82 | BioCryst Pharmaceuticals, Inc.BCRX | $2.2B | $8.70 |
| 83 | Generate Biomedicines, Inc.GENB | $2.2B | $17.12 |
| 84 | Sarepta Therapeutics, Inc.SRPT | $2.2B | $20.67 |
| 85 | Aurinia Pharmaceuticals Inc.AUPH | $2.2B | $16.96 |
| 86 | Trevi Therapeutics, Inc.TRVI | $2.2B | $15.21 |
| 87 | SELLAS Life Sciences Group, Inc.SLS | $2.1B | $11.53 |
| 88 | UroGen Pharma Ltd.URGN | $2.1B | $43.95 |
| 89 | Nuvation Bio Inc.NUVB | $2.1B | $6.07 |
| 90 | Biohaven Ltd.BHVN | $2.1B | $13.89 |
| 91 | ADMA Biologics, Inc.ADMA | $2.1B | $8.95 |
| 92 | Kodiak Sciences Inc.KOD | $2.1B | $32.85 |
| 93 | Vericel CorporationVCEL | $2.0B | $40.03 |
| 94 | Zymeworks Inc.ZYME | $2.0B | $27.48 |
| 95 | Zenas BioPharma, Inc.ZBIO | $2.0B | $31.97 |
| 96 | Maravai LifeSciences Holdings, Inc.MRVI | $2.0B | $7.27 |
| 97 | Agios Pharmaceuticals, Inc.AGIO | $2.0B | $33.61 |
| 98 | Rapport Therapeutics, Inc. Common StockRAPP | $2.0B | $41.95 |
| 99 | Nektar TherapeuticsNKTR | $2.0B | $68.36 |
| 100 | Fortrea Holdings Inc.FTRE | $1.9B | $20.28 |
| 101 | Hemab Therapeutics Holdings, Inc. Common StockCOAG | $1.9B | $41.22 |
| 102 | Stoke Therapeutics, Inc.STOK | $1.9B | $28.93 |
| 103 | Recursion Pharmaceuticals, Inc.RXRX | $1.9B | $3.54 |
| 104 | Vir Biotechnology, Inc.VIR | $1.8B | $10.92 |
| 105 | Xencor, Inc.XNCR | $1.8B | $24.59 |
| 106 | Septerna IncSEPN | $1.8B | $39.50 |
| 107 | Intellia Therapeutics, Inc.NTLA | $1.7B | $12.26 |
| 108 | Kailera Therapeutics, Inc.KLRA | $1.7B | $12.92 |
| 109 | Taysha Gene Therapies, Inc.TSHA | $1.7B | $5.16 |
| 110 | Novavax, Inc.NVAX | $1.6B | $10.00 |
| 111 | AnaptysBio, Inc.ANAB | $1.6B | $55.06 |
| 112 | Absci CorporationABSI | $1.6B | $9.27 |
| 113 | Syndax Pharmaceuticals, Inc.SNDX | $1.6B | $17.68 |
| 114 | Innoviva, Inc.INVA | $1.6B | $21.05 |
| 115 | Inhibrx Biosciences Inc.INBX | $1.5B | $104.73 |
| 116 | Kardigan, Inc.KARD | $1.5B | $16.69 |
| 117 | Bicara Therapeutics Inc. Common StockBCAX | $1.5B | $22.59 |
| 118 | Avalyn Pharma Inc. Common StockAVLN | $1.5B | $33.43 |
| 119 | Tyra Biosciences, Inc.TYRA | $1.5B | $24.43 |
| 120 | Ultragenyx Pharmaceutical Inc.RARE | $1.4B | $14.50 |
| 121 | Xeris Biopharma Holdings, Inc.XERS | $1.4B | $8.16 |
| 122 | Damora Therapeutics, Inc.DMRA | $1.4B | $22.78 |
| 123 | First Tracks Biotherapeutics IncTRAX | $1.4B | $39.20 |
| 124 | Omeros CorporationOMER | $1.3B | $18.45 |
| 125 | ORIC Pharmaceuticals, Inc.ORIC | $1.3B | $12.88 |
| 126 | ArriVent BioPharma, Inc.AVBP | $1.3B | $28.36 |
| 127 | Cullinan Therapeutics, Inc.CGEM | $1.3B | $21.36 |
| 128 | Maze Therapeutics, Inc.MAZE | $1.3B | $23.44 |
| 129 | Aktis Oncology, Inc.AKTS | $1.2B | $22.86 |
| 130 | MeiraGTx Holdings plcMGTX | $1.2B | $13.05 |
| 131 | LB Pharmaceuticals Inc Common StockLBRX | $1.2B | $42.14 |
| 132 | Vor Biopharma Inc.VOR | $1.2B | $21.89 |
| 133 | Seaport Therapeutics, Inc. Common StockSPTX | $1.2B | $21.82 |
| 134 | MannKind CorporationMNKD | $1.1B | $3.58 |
| 135 | Apnimed, Inc.APMD | $1.1B | $28.11 |
| 136 | Odyssey Therapeutics, Inc.ODTX | $1.1B | $23.22 |
| 137 | Savara Inc.SVRA | $1.1B | $5.42 |
| 138 | Alto Neuroscience, Inc.ANRO | $1.1B | $30.98 |
| 139 | Replimune Group, Inc.REPL | $1.1B | $12.87 |
| 140 | Monte Rosa Therapeutics, Inc.GLUE | $1.1B | $12.60 |
| 141 | Corvus Pharmaceuticals, Inc.CRVS | $1.1B | $12.55 |
| 142 | Jade Biosciences, Inc.JBIO | $1.0B | $17.14 |
| 143 | Kura Oncology, Inc.KURA | $1.0B | $11.72 |
| 144 | Janux Therapeutics, Inc.JANX | $1.0B | $16.86 |
| 145 | Arbutus Biopharma CorpABUS | $1.0B | $5.07 |
| 146 | SpyGlass Pharma, Inc. Common StockSGP | $980.6M | $29.33 |
| 147 | Alumis Inc.ALMS | $965.2M | $7.82 |
| 148 | Lexicon Pharmaceuticals, Inc.LXRX | $903.9M | $2.04 |
| 149 | Theravance Biopharma IncTBPH | $883.2M | $17.04 |
| 150 | Avalo Therapeutics, Inc.AVTX | $877.3M | $16.69 |
| 151 | Wave Life Sciences Ltd.WVE | $874.9M | $4.44 |
| 152 | Solid Biosciences Inc.SLDB | $873.2M | $8.87 |
| 153 | Olema Pharmaceuticals, Inc.OLMA | $864.7M | $9.90 |
| 154 | Sana Biotechnology, Inc.SANA | $862.7M | $3.10 |
| 155 | Rigel Pharmaceuticals, Inc.RIGL | $848.3M | $45.85 |
| 156 | Geron CorporationGERN | $846.8M | $1.32 |
| 157 | Ardelyx, Inc.ARDX | $835.0M | $3.38 |
| 158 | Candel Therapeutics, Inc.CADL | $830.9M | $11.34 |
| 159 | Achieve Life Sciences, Inc.ACHV | $812.0M | $7.91 |
| 160 | Climb Bio, Inc.CLYM | $805.1M | $14.06 |
| 161 | Gyre Therapeutics, Inc.GYRE | $800.5M | $7.18 |
| 162 | Design Therapeutics, Inc.DSGN | $800.1M | $12.81 |
| 163 | 4D Molecular Therapeutics, Inc.FDMT | $767.4M | $14.68 |
| 164 | Aclaris Therapeutics, Inc.ACRS | $754.2M | $5.40 |
| 165 | Zevra Therapeutics, Inc.ZVRA | $699.9M | $11.84 |
| 166 | Immix Biopharma, Inc.IMMX | $692.0M | $12.72 |
| 167 | Monopar Therapeutics Inc.MNPR | $688.0M | $102.70 |
| 168 | MiMedx Group, Inc.MDXG | $683.6M | $4.69 |
| 169 | Annexon, Inc.ANNX | $683.2M | $4.17 |
| 170 | Aura Biosciences, Inc.AURA | $681.6M | $6.59 |
| 171 | Verastem, Inc.VSTM | $663.4M | $7.55 |
| 172 | OmniAb, Inc.OABI | $643.7M | $4.44 |
| 173 | Altimmune, Inc.ALT | $630.1M | $3.24 |
| 174 | Phathom Pharmaceuticals, Inc.PHAT | $627.0M | $7.75 |
| 175 | Crescent Biopharma, Inc.CBIO | $622.9M | $16.77 |
| 176 | CytomX Therapeutics, Inc.CTMX | $613.9M | $2.82 |
| 177 | CorMedix Inc.CRMD | $611.1M | $7.79 |
| 178 | Bright Minds Biosciences Inc.DRUG | $602.4M | $61.55 |
| 179 | Allogene Therapeutics, Inc.ALLO | $597.1M | $1.73 |
| 180 | Nuvectis Pharma, Inc.NVCT | $567.3M | $21.38 |
| 181 | Prime Medicine, Inc.PRME | $567.1M | $3.14 |
| 182 | Capricor Therapeutics, Inc.CAPR | $541.8M | $9.42 |
| 183 | Arvinas, Inc.ARVN | $536.2M | $8.31 |
| 184 | Shattuck Labs, Inc.STTK | $528.7M | $5.85 |
| 185 | Scribe Therapeutics Inc.SCTX | $520.1M | $32.14 |
| 186 | Tectonic Therapeutic, Inc.TECX | $513.4M | $27.21 |
| 187 | Neurogene Inc.NGNE | $512.2M | $32.41 |
| 188 | Ginkgo Bioworks Holdings, Inc.DNA | $512.1M | $7.84 |
| 189 | Ovid Therapeutics Inc.OVID | $503.9M | $2.70 |
| 190 | Assembly Biosciences, Inc.ASMB | $502.2M | $25.34 |
| 191 | Contineum Therapeutics, Inc.CTNM | $497.0M | $13.21 |
| 192 | Puma Biotechnology, Inc.PBYI | $484.6M | $9.52 |
| 193 | Arcturus Therapeutics Holdings Inc.ARCT | $481.2M | $16.93 |
| 194 | MapLight Therapeutics, Inc.MPLT | $480.4M | $11.32 |
| 195 | Eikon Therapeutics, Inc. Common StockEIKN | $465.6M | $8.60 |
| 196 | Prothena Corporation plcPRTA | $442.9M | $8.46 |
| 197 | Relmada Therapeutics, Inc.RLMD | $440.5M | $4.20 |
| 198 | Opus Genetics, Inc.IRD | $435.9M | $5.28 |
| 199 | Kyverna Therapeutics, Inc.KYTX | $428.0M | $7.04 |
| 200 | REGENXBIO Inc.RGNX | $424.7M | $8.22 |
| 201 | Atea Pharmaceuticals, Inc.AVIR | $420.9M | $5.26 |
| 202 | Cabaletta Bio, Inc.CABA | $420.7M | $2.58 |
| 203 | Editas Medicine, Inc.EDIT | $417.4M | $2.72 |
| 204 | Artiva Biotherapeutics, Inc.ARTV | $412.6M | $8.44 |
| 205 | ARS Pharmaceuticals, Inc.SPRY | $412.1M | $4.15 |
| 206 | Turn Therapeutics Inc.TTRX | $411.7M | $13.82 |
| 207 | Larimar Therapeutics, Inc.LRMR | $394.8M | $3.80 |
| 208 | BridgeBio Oncology Therapeutics Inc.BBOT | $391.7M | $4.89 |
| 209 | Benitec Biopharma Inc.BNTC | $390.3M | $11.36 |
| 210 | Rocket Pharmaceuticals, Inc.RCKT | $382.2M | $3.50 |
| 211 | Rezolute, Inc.RZLT | $380.4M | $3.95 |
| 212 | C4 Therapeutics, Inc.CCCC | $377.6M | $3.42 |
| 213 | Fennec Pharmaceuticals Inc.FENC | $374.5M | $10.78 |
| 214 | Enanta Pharmaceuticals, Inc.ENTA | $364.1M | $12.52 |
| 215 | Sagimet Biosciences Inc.SGMT | $363.9M | $11.17 |
| 216 | Keros Therapeutics, Inc.KROS | $363.5M | $11.36 |
| 217 | Ocugen, Inc.OCGN | $349.3M | $1.03 |
| 218 | Orchestra BioMed Holdings, Inc.OBIO | $346.1M | $5.78 |
| 219 | Evommune, Inc.EVMN | $340.1M | $9.37 |
| 220 | EyePoint Pharmaceuticals, Inc.EYPT | $334.5M | $3.99 |
| 221 | Compass Therapeutics, Inc.CMPX | $333.2M | $1.85 |
| 222 | X4 Pharmaceuticals, Inc.XFOR | $330.1M | $3.50 |
| 223 | Lexeo Therapeutics, Inc. Common StockLXEO | $328.2M | $4.18 |
| 224 | Sionna Therapeutics, Inc.SION | $324.2M | $7.18 |
| 225 | Q32 Bio Inc.QTTB | $323.2M | $10.86 |
| 226 | Abeona Therapeutics Inc.ABEO | $318.6M | $5.59 |
| 227 | SAB Biotherapeutics, Inc.SABS | $318.5M | $3.50 |
| 228 | Vanda Pharmaceuticals Inc.VNDA | $307.3M | $5.11 |
| 229 | BioAge Labs Inc.BIOA | $304.6M | $8.09 |
| 230 | Inhibikase Therapeutics, Inc.IKT | $303.7M | $2.30 |
| 231 | Agenus Inc.AGEN | $300.7M | $7.22 |
| 232 | Fate Therapeutics, Inc.FATE | $293.7M | $2.52 |
| 233 | Upstream Bio, Inc.UPB | $289.0M | $5.31 |
| 234 | Fulcrum Therapeutics, Inc.FULC | $287.6M | $3.77 |
| 235 | Greenwich LifeSciences, Inc.GLSI | $269.9M | $18.39 |
| 236 | Entrada Therapeutics, Inc.TRDA | $267.9M | $6.90 |
| 237 | Lyell Immunopharma, Inc.LYEL | $264.6M | $10.80 |
| 238 | MacroGenics, Inc.MGNX | $262.5M | $4.13 |
| 239 | Prelude Therapeutics IncorporatedPRLD | $260.2M | $4.57 |
| 240 | Lineage Cell Therapeutics, Inc.LCTX | $256.8M | $1.03 |
| 241 | Foghorn Therapeutics Inc.FHTX | $246.6M | $4.20 |
| 242 | Galectin Therapeutics Inc.GALT | $244.3M | $3.71 |
| 243 | Akebia Therapeutics, Inc.AKBA | $240.2M | $0.90 |
| 244 | Niagen Bioscience IncNAGE | $238.1M | $2.99 |
| 245 | ALX Oncology Holdings Inc.ALXO | $234.1M | $1.74 |
| 246 | Whitehawk Therapeutics IncWHWK | $232.6M | $4.08 |
| 247 | Cartesian Therapeutics, Inc.RNAC | $230.9M | $7.86 |
| 248 | Anavex Life Sciences Corp.AVXL | $223.3M | $2.41 |
| 249 | Invivyd, Inc.IVVD | $219.8M | $0.75 |
| 250 | Zentalis Pharmaceuticals, Inc.ZNTL | $219.3M | $3.08 |
| 251 | Pyxis Oncology, Inc.PYXS | $216.0M | $3.41 |
| 252 | Protara Therapeutics, Inc.TARA | $208.0M | $3.70 |
| 253 | PepGen Inc.PEPG | $205.4M | $2.97 |
| 254 | Alector, Inc.ALEC | $205.4M | $1.85 |
| 255 | Eledon Pharmaceuticals, Inc.ELDN | $204.5M | $2.65 |
| 256 | Nkarta, Inc.NKTX | $201.0M | $2.81 |
| 257 | Coherus Oncology, Inc.CHRS | $190.0M | $1.23 |
| 258 | Acumen Pharmaceuticals, Inc.ABOS | $185.6M | $2.57 |
| 259 | Voyager Therapeutics, Inc.VYGR | $183.7M | $3.04 |
| 260 | Tonix Pharmaceuticals Holding Corp.TNXP | $182.0M | $11.42 |
| 261 | AN2 Therapeutics, Inc.ANTX | $176.5M | $4.90 |
| 262 | MediWound Ltd.MDWD | $171.5M | $13.35 |
| 263 | Atrium Therapeutics, Inc.RNA | $163.5M | $9.56 |
| 264 | Century Therapeutics, Inc.IPSC | $162.8M | $1.88 |
| 265 | Canton Strategic Holdings IncCNTN | $162.0M | $2.10 |
| 266 | Immuneering CorporationIMRX | $161.9M | $4.46 |
| 267 | Minerva Neurosciences, Inc.NERV | $161.2M | $3.46 |
| 268 | Armata Pharmaceuticals, Inc.ARMP | $150.5M | $4.10 |
| 269 | Sutro Biopharma, Inc.STRO | $149.8M | $15.48 |
| 270 | Spruce Biosciences, Inc.SPRB | $148.2M | $53.86 |
| 271 | Tenaya Therapeutics, Inc.TNYA | $145.9M | $0.67 |
| 272 | Codexis, Inc.CDXS | $142.0M | $1.32 |
| 273 | Immunic, Inc.IMUX | $141.0M | $10.35 |
| 274 | Neumora Therapeutics, Inc. Common StockNMRA | $139.0M | $0.75 |
| 275 | ADC Therapeutics S.A.ADCT | $134.8M | $1.06 |
| 276 | Corbus Pharmaceuticals Holdings, Inc.CRBP | $134.5M | $7.26 |
| 277 | TuHURA Biosciences, Inc.HURA | $133.1M | $2.09 |
| 278 | Caribou Biosciences, Inc.CRBU | $129.9M | $1.31 |
| 279 | LENZ Therapeutics, Inc.LENZ | $129.5M | $4.13 |
| 280 | Biomea Fusion, Inc.BMEA | $129.4M | $1.79 |
| 281 | MaxCyte, Inc.MXCT | $128.0M | $1.20 |
| 282 | Unicycive Therapeutics, Inc.UNCY | $127.4M | $4.77 |
| 283 | Outlook Therapeutics, Inc.OTLK | $127.3M | $0.68 |
| 284 | Surrozen, Inc.SRZN | $126.7M | $16.94 |
| 285 | Cibus, Inc.CBUS | $124.4M | $1.63 |
| 286 | Nautilus Biotechnolgy, Inc.NAUT | $123.7M | $0.97 |
| 287 | Aardvark Therapeutics, Inc. Common StockAARD | $121.0M | $5.53 |
| 288 | OnKure Therapeutics, Inc.OKUR | $119.9M | $2.96 |
| 289 | Equillium, Inc.EQ | $119.5M | $1.89 |
| 290 | Korro Bio, Inc.KRRO | $117.4M | $11.80 |
| 291 | Genelux CorporationGNLX | $113.4M | $2.53 |
| 292 | Coya Therapeutics, Inc.COYA | $111.7M | $4.76 |
| 293 | Black Diamond Therapeutics, Inc.BDTX | $110.6M | $1.93 |
| 294 | Polaryx Therapeutics, Inc. Common StockPLYX | $106.7M | $2.14 |
| 295 | Seer, Inc.SEER | $105.6M | $1.92 |
| 296 | Vivani Medical, Inc.VANI | $104.3M | $1.21 |
| 297 | Cardiff Oncology, Inc.CRDF | $100.2M | $1.30 |
| 298 | Cue Biopharma, Inc.CUE | $99.4M | $37.84 |
| 299 | Humacyte, Inc.HUMA | $96.6M | $0.58 |
| 300 | NeurAxis, Inc.NRXS | $95.2M | $7.63 |
| 301 | Cognition Therapeutics, Inc.CGTX | $94.9M | $1.06 |
| 302 | Anixa Biosciences, Inc.ANIX | $93.9M | $2.76 |
| 303 | Fractyl Health, Inc.GUTS | $93.7M | $0.59 |
| 304 | Nutriband Inc.NTRB | $93.0M | $7.65 |
| 305 | Rallybio CorporationRLYB | $91.1M | $17.16 |
| 306 | ImmuCell CorporationICCC | $90.3M | $9.98 |
| 307 | Neonc Technologies Holdings, Inc.NTHI | $88.4M | $3.41 |
| 308 | Atara Biotherapeutics, Inc.ATRA | $87.5M | $9.71 |
| 309 | CAMP4 Therapeutics CorporationCAMP | $85.6M | $4.03 |
| 310 | Precision BioSciences, Inc.DTIL | $85.6M | $6.67 |
| 311 | MAIA Biotechnology, Inc.MAIA | $85.1M | $1.40 |
| 312 | Adicet Bio, Inc.ACET | $84.2M | $9.01 |
| 313 | Inovio Pharmaceuticals, Inc.INO | $83.6M | $1.21 |
| 314 | Fortress Biotech, Inc.FBIO | $83.4M | $2.51 |
| 315 | OS Therapies IncorporatedOSTX | $83.3M | $1.83 |
| 316 | Aldeyra TheALDX | $83.2M | $1.38 |
| 317 | vTv Therapeutics Inc.VTVT | $82.2M | $31.40 |
| 318 | Verrica Pharmaceuticals Inc.VRCA | $79.9M | $4.65 |
| 319 | RenovoRx, Inc.RNXT | $77.9M | $1.73 |
| 320 | PMV Pharmaceuticals, Inc.PMVP | $77.9M | $1.46 |
| 321 | Pelthos Therapeutics Inc.PTHS | $77.8M | $22.38 |
| 322 | Telomir Pharmaceuticals, Inc. Common StockTELO | $77.0M | $1.12 |
| 323 | Gossamer Bio, Inc.GOSS | $73.0M | $11.94 |
| 324 | Acrivon Therapeutics, Inc. Common StockACRV | $72.8M | $1.70 |
| 325 | Champions Oncology, Inc.CSBR | $70.6M | $5.08 |
| 326 | Pliant Therapeutics, Inc.PLRX | $70.0M | $1.13 |
| 327 | Cingulate Inc.CING | $69.4M | $5.15 |
| 328 | Kalaris Therapeutics IncKLRS | $69.0M | $3.16 |
| 329 | Spero Therapeutics, Inc.SPRO | $64.8M | $1.12 |
| 330 | Boundless Bio, Inc.BOLD | $62.9M | $2.80 |
| 331 | Eloxx Pharmaceuticals, Inc.ELOX | $60.3M | $17.55 |
| 332 | Heron Therapeutics, Inc.HRTX | $59.8M | $0.32 |
| 333 | Xilio Therapeutics, Inc.XLO | $59.4M | $9.04 |
| 334 | NRx Pharmaceuticals, Inc.NRXP | $58.6M | $3.39 |
| 335 | MiNK Therapeutics, Inc.INKT | $58.3M | $11.71 |
| 336 | INmune Bio, Inc.INMB | $58.0M | $2.18 |
| 337 | eXoZymes, Inc.EXOZ | $57.5M | $6.19 |
| 338 | ImageneBio IncIMA | $56.6M | $5.02 |
| 339 | Rani Therapeutics Holdings, Inc.RANI | $55.6M | $0.85 |
| 340 | Tenax Therapeutics, Inc.TENX | $49.3M | $1.86 |
| 341 | Instil Bio, Inc.TIL | $48.9M | $7.21 |
| 342 | Annovis Bio, Inc.ANVS | $46.8M | $1.10 |
| 343 | Seres Therapeutics, Inc.MCRB | $39.7M | $4.10 |
